Related references
Note: Only part of the references are listed.Tuberculosis Drug Discovery: Challenges and New Horizons
Guilherme F. S. Fernandes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Veronique A. Dartois et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
Barbara Bosch et al.
CELL (2021)
The mycobacterial cell envelope - a moving target
Charles L. Dulberger et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite
Fraser Cunningham et al.
ACS INFECTIOUS DISEASES (2020)
Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA
Ana C. Puhl et al.
ACS OMEGA (2020)
A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA
Daigo Inoyama et al.
CELL CHEMICAL BIOLOGY (2020)
Antitubercular Triazines: Optimization and Intrabacterial Metabolism
Xin Wang et al.
CELL CHEMICAL BIOLOGY (2020)
Mycobacterial drug discovery
Katherine A. Abrahams et al.
RSC MEDICINAL CHEMISTRY (2020)
Genomewide Assessment of Mycobacterium tuberculosis Conditionally Essential Metabolic Pathways
Yusuke Minato et al.
MSYSTEMS (2019)
Intrabacterial Metabolism Obscures the Successful Prediction of an InhA Inhibitor of Mycobacterium tuberculosis
Xin Wang et al.
ACS INFECTIOUS DISEASES (2019)
TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities
Allison F. Carey et al.
PLOS PATHOGENS (2018)
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
Pradeep Kumar et al.
MBIO (2018)
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
Michael A. DeJesus et al.
MBIO (2017)
Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform
Jeremy M. Rock et al.
NATURE MICROBIOLOGY (2017)
Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity
Gopal R. Bommineni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of KasA as the cellular target of an anti-tubercular scaffold
Katherine A. Abrahams et al.
NATURE COMMUNICATIONS (2016)
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery
Maria Jose Rebollo-Lopez et al.
PLOS ONE (2015)
The Protonation State of Catalytic Residues in the Resting State of KasA Revisited: Detailed Mechanism for the Activation of KasA by Its Own Substrate
Wook Lee et al.
BIOCHEMISTRY (2014)
Mycolic Acids: Structures, Biosynthesis, and Beyond
Hedia Marrakchi et al.
CHEMISTRY & BIOLOGY (2014)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
Thiolactomycin-based β-Ketoacyl-AcpM Synthase A (KasA) Inhibitors FRAGMENT-BASED INHIBITOR DISCOVERY USING TRANSIENT ONE-DIMENSIONAL NUCLEAR OVERHAUSER EFFECT NMR SPECTROSCOPY
Kanishk Kapilashrami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target from Mycobacterium Tuberculosis
Johannes Schiebel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
Regina Wilson et al.
NATURE CHEMICAL BIOLOGY (2013)
Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis
Yanjia J. Zhang et al.
PLOS PATHOGENS (2012)
Elucidation of the Protonation States of the Catalytic Residues in mtKasA: Implications for Inhibitor Design
Wook Lee et al.
BIOCHEMISTRY (2011)
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
Jennifer E. Griffin et al.
PLOS PATHOGENS (2011)
Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
Joaquin Rullas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Slow Onset Inhibition of Bacterial β-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin
Carl A. Machutta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Dual Function of the Mycobacterium tuberculosis FadD32 Required for Mycolic Acid Biosynthesis
Mathieu Leger et al.
CHEMISTRY & BIOLOGY (2009)
The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis
Sabine Gavalda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Platensimycin Activity against Mycobacterial β-Ketoacyl-ACP Synthases
Alistair K. Brown et al.
PLOS ONE (2009)
Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by Thiolactomycin
Sylvia R. Luckner et al.
STRUCTURE (2009)
Inhibitors of Fabl, an enzyme drug target in the bacterial fatty acid biosynthesis pathway
Hao Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state
Benoit Zuber et al.
JOURNAL OF BACTERIOLOGY (2008)
Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure
Christian Hoffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Mycobacterium tuberculosis FAS-II condensing enzymes:: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development
Apoorva Bhatt et al.
MOLECULAR MICROBIOLOGY (2007)
Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice
Apoorva Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Catherine Vilcheze et al.
NATURE MEDICINE (2006)
Structure-activity relationships at the 5-position of thiolactomycin:: An intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli
P Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms
D Portevin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Purification and biochemical characterization of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthases KasA and KasB
ML Schaeffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
L Kremer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
